Skip to main content

UBS Group AG

Position in ATHE — Alterity Therapeutics Ltd

CIK 1610520 ZURICH, V8

Position in ATHE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$26
-$44,837 QoQ
Shares Held
5
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 22 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATHE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,173,304 across 562 Biotechnology names. ATHE ranks #538 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ATHE

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26 5
2025-03-31 $44,863 13,004
2024-12-31 $1,270 384
2024-09-30 $16,616 12,685
2024-06-30 $3 2
2024-03-31 $4 2
2023-09-30 $314 127
2022-03-31 $8,704 10,487
2021-12-31 $9,791 13,599
2021-06-30 $6,055 4,658
2021-03-31 $100 70
2020-12-31 $2,566 1,915
2020-09-30 $480 238
2020-06-30 $63,205 53,114
2020-03-31 $1,846 3,077